A.R.T. Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-22,759
| Closed | -$1.69M | – | 920 |
|
|
2016
Q2 | $1.69M | Buy |
+22,759
| New | +$1.69M | 0.08% | 366 |
|
|
2015
Q3 | – | Sell |
-58,420
| Closed | -$3.68M | – | 1481 |
|
|
2015
Q2 | $3.68M | Buy |
+58,420
| New | +$3.68M | 0.12% | 235 |
|
|
2015
Q1 | – | Sell |
-71,470
| Closed | -$2.37M | – | 1562 |
|
|
2014
Q4 | $2.37M | Sell |
71,470
-35,865
| -33% | -$1.19M | 0.09% | 333 |
|
|
2014
Q3 | $3.15M | Buy |
107,335
+48,335
| +82% | +$1.42M | 0.15% | 199 |
|
|
2014
Q2 | $2.29M | Buy |
+59,000
| New | +$2.29M | 0.12% | 241 |
|
|
2013
Q4 | – | Sell |
-68,729
| Closed | -$1.86M | – | 1394 |
|
|
2013
Q3 | $1.86M | Sell |
68,729
-37,141
| -35% | -$1M | 0.1% | 292 |
|
|
2013
Q2 | $2.47M | Buy |
+105,870
| New | +$2.47M | 0.08% | 339 |
|